Market Analysis and Insights: Global Intracranial Monitoring Equipment Market
Due to the COVID-19 pandemic, the global Intracranial Monitoring Equipment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Invasive Monitoring accounting for % of the Intracranial Monitoring Equipment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Traumatic Brain Injury segment is altered to an % CAGR throughout this forecast period.
China Intracranial Monitoring Equipment market size is valued at US$ million in 2021, while the US and Europe Intracranial Monitoring Equipment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Intracranial Monitoring Equipment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Intracranial Monitoring Equipment include Johnson & Johnson, Spiegelberg, Sophysa, Zhongli Medical, Kejin, Neural Analytics, Nihon Kohden, Integra Lifesciences and Vittamed, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Intracranial Monitoring Equipment Scope and Segment
Intracranial Monitoring Equipment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intracranial Monitoring Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Invasive Monitoring
Noninvasive Monitoring
Segment by Application
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Subarachnoid Hemorrhage
Other
By Company
Johnson & Johnson
Spiegelberg
Sophysa
Zhongli Medical
Kejin
Neural Analytics
Nihon Kohden
Integra Lifesciences
Vittamed
Raumedic Ag
Haiweikang
Headsense
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE